Abstract
Background:
Multiple sclerosis subpial cortical lesions are prevalent and associated with disability but difficult to detect on MRI. Inversion recovery susceptibility weighted imaging with enhanced T2 weighting (IR-SWIET) and T1/T2 ratio imaging have been proposed for cortical lesion detection on 3 tesla (T) MRI.
Objectives:
To assess cortical lesion detection using IR-SWIET and T1/T2 ratio imaging.
Methods:
Cortical lesions were identified in 20 persons with MS (pwMS) independently on six image sets: T1 weighted (w) magnetization prepared 2 rapid acquisition gradient echoes (MP2RAGE) + T2w fluid attenuated inversion recovery (FLAIR) alone or with T1/T2, IR-SWIET single acquisition (×1), average of two (×2) or median of four (×4) acquisitions, or denoised single acquisition (IR-SWIET×1DN). In 10 additional pwMS with 7T-based cortical lesion segmentations, lesions were identified on MP2RAGE + FLAIR + IR-SWIET×1DN.
Results:
Median subpial lesions identified on MP2RAGE + FLAIR was 0 (interquartile range (IQR) 2) vs 0 with T1/T2 (IQR 1, p=0.07), 1 with IR-SWIET×1 (IQR 6, p=0.42), 5 with IR-SWIET×2 (IQR 5, p=0.008), 4 with IR-SWIET×4 (IQR 6, p=0.008), and 4 with IR-SWIET×1DN (IQR 6, p=0.008). Versus 7T, IR-SWIET×1DN detected subpial lesions with similar sensitivity to IR-SWIET×2.
Conclusions:
IR-SWIET, but not T1/T2, improves subpial cortical lesion detection. Denoising may be an efficient and sensitive alternative to multi-acquisition averaging.
Keywords: multiple sclerosis, subpial lesions, cortical lesions, magnetic resonance imaging
Introduction
Multiple sclerosis (MS) cortical lesions are commonly seen on histopathology and ultra-high field (7 tesla, T) MRI.1-4 Despite inclusion of cortical lesions in the 2017 and 2024 McDonald diagnostic criteria, visualization of cortical lesions on 3T MRI remains challenging.5,6 The most commonly used MRI sequence at 3T for cortical lesion detection, double inversion recovery (DIR), demonstrates good sensitivity for leukocortical lesions but only 7% sensitivity for subpial lesions.7 T1 weighted (w) magnetization prepared 2 rapid acquisition gradient echoes (MP2RAGE) achieves a similar cortical lesion detection rate with better grey-white matter contrast, but likewise is insensitive to subpial lesions.8,9 Subpial lesions are of particular interest as they are the most frequent subtype of cortical lesion in MS, are associated with disability and progressive disease, may form independently from white matter lesions and other types of cortical lesions, and might be specific to MS.1,3
We recently developed inversion recovery susceptibility weighted imaging with enhanced T2 weighting (IR-SWIET), an MRI method designed to improve subpial lesion detection at 3T by increasing T2 and T2* weighting and suppressing cerebrospinal fluid signal.9 In a single center study including ten persons with MS (pwMS) with known cortical lesions on 7T imaging, 3T IR-SWIET improved subpial lesion detection compared to other 3T methods, including DIR.9
At the sub-millimeter resolution required to image cortical lesions, IR-SWIET images are limited by low signal-to-noise ratio (SNR). Averaging multiple IR-SWIET acquisitions enhances SNR, lesion-to-background contrast, and subpial lesion detection, at a substantial cost in scan time.9 An alternative is a post-acquisition denoising algorithm such as non-local means filtering.10, 11 The sensitivity of denoised IR-SWIET images for cortical lesions has not previously been tested.
Another method that has been proposed to increase cortical lesion conspicuity at 3T is T1/T2 ratio images, in which T1 and T2w images are co-registered and divided.12,13 Contrast between cortical lesions and normal-appearing cortex is greater on T1/T2 images than on T1 or T2w images alone or on IR-SWIET, and lesion conspicuity is improved relative to conventional sequences in clinical trial data but prospective cortical lesion detection on T1/T2 images has not been tested.12,13
The primary aim of this study was to determine the most feasible and sensitive 3T MRI approach for cortical lesion detection by comparing IR-SWIET, T1w MP2RAGE, T2w fluid-attenuated inversion recovery (FLAIR), and T1/T2 ratio imaging in a multi-contrast reading paradigm. Specifically, we evaluated whether the addition of IR-SWIET or T1/T2 improves cortical lesion detection compared with MP2RAGE and FLAIR alone, and how the number of IR-SWIET acquisitions (one, average of two or four repetitions, or a denoised single acquisition) affects cortical lesion detection.
Materials and methods
Data acquisition
Data collection was approved by the institutional review boards of the University of Vermont (UVM) and the National Institutes of Health (NIH), and informed consent was obtained from all participants. 71 pwMS underwent 3T brain MRI at UVM as a part of an observational study. Scans for 11 participants were excluded due to artifacts. All participants underwent clinical testing including Expanded Disability Status Scale (EDSS), Symbol Digit Modalities Test (SDMT), timed 25-foot walk (T25FW), and 9-hole peg test (9-HPT). In addition, data from 10 pwMS who were enrolled in an observational study at the NIH with prior 3T brain MRI including IR-SWIET as well as 7T brain MRI were analyzed.9
MRI acquisition and image processing
Brain MRIs at UVM were performed on a 3T Philips Achieva scanner (Philips Healthcare, Eindhoven, the Netherlands) equipped with a 32-channel head coil. The imaging protocol included IR-SWIET (acquired four times per session, acquired at 0.8 mm × 0.8 mm × 0.64 mm, reconstructed at 0.64 mm3 resolution), T1w MP2RAGE (1 mm3), and T2w FLAIR (0.89 × 0.89 × 1 mm). The four IR-SWIET acquisitions were rigidly co-registered (Advanced Normalization Tools [ANTs], version 2.5.3). Average of two (×2) and median of four (×4) IR-SWIET images were generated. A single acquisition was denoised (×1DN) using ANTs Denoise (patch radius = 1, search radius = 2, noise variance σ = 0.010); these conservative parameters were chosen to balance noise reduction with preservation of anatomical and pathological detail.14 The first acquisition was always used for IR-SWIET×1 and IR-SWIET×1DN, and the first two acquisitions were always used for IR-SWIET×2. FLAIR images were upsampled to 0.8 mm3, and all IR-SWIET images and MP2RAGE were rigidly registered (ANTs) to the upsampled FLAIR, using a mutual information cost function and linear interpolation. T1/T2 ratio images were generated by dividing the T1w MP2RAGE uniform denoised images (generated on the scanner) by the T2w FLAIR images. White matter lesions were segmented on FLAIR images using FLAMeS, followed by manual adjustment.15
For the NIH cohort, which was previously used to determine the sensitivity of cortical lesion detection using IR-SWIET, IR-SWIET (acquired four times) and FLAIR were obtained on a 3T Philips Achieva scanner and MP2RAGE on a 3T Siemens Magnetom Skyra scanner, each with a 32-channel head coil. 7T brain MRI included MP2RAGE (0.5 mm3, median of four acquisitions) and T2*-weighted gradient-recalled echo (GRE, 0.5 mm3) on a Siemens whole-body research system. Image processing details have been previously described.9
Detailed acquisition parameters for both cohorts are provided in Supplementary Table 1.
Cortical lesion detection comparison (UVM cohort)
20 individuals from the UVM cohort were selected for cortical lesion detection comparison based on the availability of high-quality images and the presence of at least one visible cortical lesion identified on initial screening by an expert rater (ESB) with over eight years of cortical lesion segmentation experience. Participant demographics are summarized in Table 1.
Table 1.
University of Vermont cohort demographic and clinical characteristics
| Female (n, %) | 16 (80%) |
| Age (years) 1 | 47 ± 8 |
| Clinical subtype (n, %) | |
| Relapsing-remitting | 17 (85%) |
| Primary progressive | 1 (5%) |
| Secondary progressive | 2 (10%) |
| Years since diagnosis 1 | 12 ± 8 |
| Disease modifying therapy (n, %) | |
| High efficacy | 11 (55%) |
| Moderate efficacy | 1 (5%) |
| Low efficacy | 2 (10%) |
| None | 6 (30%) |
| Expanded disability status scale 2 | 2.5 (2.5) [1.5–7.0] |
| 9-hole peg test (dominant hand) (seconds) 1 | 21.0 ± 5.1 |
| Timed 25-foot walk (seconds) 1 | 4.4 ± 0.9 |
| Symbol Digit Modalities Test 1 | 58 ± 8 |
| T2 weighted lesion volume (mm3) 2 | 7071 (10124) [228–55362] |
Disease modifying therapy efficacy classifications were defined as: high efficacy (ocrelizumab, ofatumumab, cladribine); moderate efficacy (dimethyl fumarate, fingolimod, teriflunomide); low efficacy (glatiramer acetate, peginterferon beta-1a, interferon beta-1a).
mean ± standard deviation
median (interquartile range) [min – max]
For each of the 20 participants, cortical lesions were initially identified and segmented independently on five sets of images:
-
1
MP2RAGE + FLAIR
-
2
MP2RAGE + FLAIR + T1/T2 ratio images
-
3
MP2RAGE + FLAIR + IR-SWIET×1
-
4
MP2RAGE + FLAIR + IR-SWIET×2
-
5
MP2RAGE + FLAIR + IR-SWIET×4
Images for sets 1-5 above were divided into five reading sets, with each subject appearing once per set and equal representation of each of the first five multi-contrast image types within each set. Images were anonymized with respect to subject identity, demographic and clinical data, and IR-SWIET acquisition number. Subsequently, a sixth multi-contrast read:
-
6.
MP2RAGE + FLAIR + IR-SWIET×1DN
was performed by the same two raters, with scans from each participant presented in a newly randomized order.
Cortical lesions were manually segmented using ITK-SNAP version 4.2.0. Images were viewed in axial, sagittal, and coronal planes simultaneously with linear interpolation enabled. Two raters (ES and KO) identified and segmented cortical lesions independently in the same order, with at least one week between each reading set. Criteria for cortical lesions included: (1) hypointense signal on MP2RAGE or T1/T2 and/or (2) hyperintensity on FLAIR and/or IR-SWIET; and (3) presence on two consecutive slices in at least one plane. Cortical lesions were categorized as leukocortical: involving both cortex and white matter but not extending to the pial surface, intracortical: confined to cortex but not extending to the pial surface; subpial: confined to cortex and touching the pial surface; and subpial with white matter (WM) involvement: extending from pial surface into white matter. Additional labels were used where definitive classification was not possible: juxtacortical vs leukocortical for lesions primarily located within the white matter but with possible cortical involvement; and possible subpial, possible intracortical, and possible leukocortical lesions. These additional lesion types were included in retrospective review analyses but not in primary lesion counts. A third rater (ESB) adjudicated all lesions identified only by one rater or for which there was disagreement on subtype.
7T validation of denoised IR-SWIET
To determine the sensitivity of IR-SWIET×1DN for cortical lesions, two raters independently identified cortical lesions on a combination of IR-SWIET×1DN, MP2RAGE, and FLAIR in 10 3T scans from participants with previous 7T-based as well as 3T-IR-SWIET-based cortical lesion segmentations (NIH cohort), using the same lesion criteria and rating protocol. Cortical lesion masks were compared to a reference standard mask previously generated using a combination of 7T T1w MP2RAGE×4 and T2*w GRE and to masks previously generated using 3T MP2RAGE, FLAIR, and IR-SWIET×2.9, 16
Statistical analysis
Cortical lesion counts were compared across the six multi-contrast reads using the Friedman test, with p-values obtained by within-subject permutation (10,000 resamples) to accommodate the large number of tied values. Post-hoc pairwise comparisons used the Wilcoxon signed-rank test, with midranks for ties and zero differences discarded before ranking; exact two-sided p values were computed, with Benjamini–Hochberg false-discovery rate (FDR) correction within each of two pre-specified comparison families (Supplementary Table 2). Cortical lesion subtype-specific analyses used the same approach. The proportion of individuals with at least one detectable cortical or subpial lesion was compared across image sets using Cochran’s Q test, with pairwise comparisons performed using McNemar’s exact test with false-discovery rate (FDR) correction. Interrater reliability was assessed using intraclass correlation coefficient (ICC) using a two-way random effects model for total lesion counts and for each cortical lesion subtype per multi-contrast read, and 95% confidence intervals were computed by subject-level bootstrap comparison approach (5000 iterations, resampling with replacement) and reported descriptively. Partial Spearman’s rank correlations (ρ), adjusting for age, were calculated between cortical lesion counts and clinical measures for each multi-contrast read, and between white matter lesion volume and clinical measures. Age alone was included as a covariate given the sample size, and a nominal significance threshold of p < 0.05 (two-tailed) was used with no adjustment for multiple comparisons due to the exploratory nature of these analyses. In the 7T cohort, true positive counts and per-participant sensitivity were compared between IR-SWIET×1DN and IR-SWIET×2 using the Wilcoxon signed-rank test with the same tie handling and exact p values.
All statistical analyses were performed using Python 3.11.8.
Results
IR-SWIET increases detection of subpial cortical lesions, with similar performance of IR-SWIET×2, IR-SWIET×4, and IR-SWIET×1DN
Cortical lesion number was compared across six image sets in 20 individuals with MS (Table 2). Total cortical lesion number differed across image sets (Friedman χ2 = 18.15, p = 0.002). Median cortical lesion number was similar in most pairwise comparisons, with the exception of higher cortical lesion number with IR-SWIET×2 (median 15, IQR 14; p = 0.011, FDR p = 0.042) and IR-SWIET×4 (median 16, IQR 14; p = 0.017, FDR p = 0.042) and lower with T1/T2 (median 8, IQR 11; p = 0.030, FDR p = 0.049) vs MP2RAGE + FLAIR alone (median 10, IQR 13).
Table 2.
Cortical lesion counts on different image sets
| Total cortical lesions |
Leukocortical lesions |
Intracortical lesions |
Subpial lesions | Subpial with white matter involvement |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Image set1 | Total | Median (IQR) [range] |
Total | Median (IQR) [range] |
Total | Median (IQR) [range] |
Total | Median (IQR) [range] |
Total | Median (IQR) [range] |
| MP2RAGE + FLAIR | 261 | 10 (13) [1–42] |
180 | 8 (9) [0–18] |
7 | 0 (0) [0–2] |
44 | 0 (2) [0–15] |
30 | 0 (3) [0–9] |
| T1/T2 | 202 | 8 (11) [1–22] |
162 | 6 (11) [0–21] |
5 | 0 (0) [0–1] |
12 | 0 (1) [0–4] |
23 | 0 (2) [0–4] |
| IR-SWIET×1 | 261 | 12 (15) [0–27] |
172 | 8 (8) [0–20] |
2 | 0 (0) [0–1] |
57 | 1 (6) [0–10] |
30 | 0 (3) [0–5] |
| IR-SWIET×2 | 309 | 15 (14) [1–46] |
171 | 7 (10) [0–18] |
2 | 0 (0) [0–1] |
96 | 5 (5) [0–23] |
40 | 1 (2) [0–12] |
| IR-SWIET×4 | 318 | 16 (14) [0–47] |
169 | 8 (10) [0–20] |
6 | 0 (1) [0–1] |
103 | 4 (6) [0–27] |
40 | 1 (4) [0–8] |
| IR-SWIET×1DN | 289 | 14 (12) [0–47] |
151 | 6 (10) [0–21] |
0 | 0 (0) [0–0] |
88 | 4 (6) [0–22] |
50 | 1 (4) [0–11] |
| Friedman test | χ2=18.15, p=0.002 | χ2=3.23, p=0.68 | χ2=12.41, p=0.02 | χ2=42.00, p<0.001 | χ2=25.12, p<0.001 | |||||
All image sets included MP2RAGE and FLAIR.
IR-SWIET: inversion recovery susceptibility weighted imaging with enhanced T2 weighting; MP2RAGE: magnetization prepared 2 rapid acquisition gradient echoes; FLAIR: fluid-attenuated inversion recovery; IQR: interquartile range; IR-SWIET×1: single IR-SWIET acquisition; IR-SWIET×2: average of two acquisitions; IR-SWIET×4: median of four acquisitions; IR-SWIET×1DN: denoised single acquisition.
Subpial cortical lesions often appeared more conspicuous on IR-SWIET compared to other image types (Figure 1). Subpial lesion detection differed significantly across image sets (Friedman χ2 = 42.00, p < 0.001). More subpial lesions were detected with IR-SWIET×2 (median 5, IQR 5; p = 0.002, FDR p = 0.008), IR-SWIET×4 (median 4, IQR 6; p = 0.003, FDR p = 0.008), and IR-SWIET×1DN (median 4, IQR 6; p = 0.005, FDR p = 0.008) compared to MP2RAGE + FLAIR alone (median 0, IQR 2). There was no increase in subpial lesion detection with IR-SWIET×1 (median 1, IQR 6, p = 0.42) (Table 2, Supplementary Table 2). There was no difference in subpial lesion detection using T1/T2 vs MP2RAGE + FLAIR alone (median 0, IQR 1, p = 0.056; FDR p = 0.07). Across IR-SWIET image sets, more subpial lesions were detected with IR-SWIET×2 (p = 0.03, FDR p = 0.03), ×4 (p = 0.01, FDR p = 0.03), and ×1DN (p = 0.02, FDR p = 0.03) than with IR-SWIET×1. The number of subpial lesions detected using IR-SWIET×1DN did not differ significantly from IR-SWIET×2 or ×4 (p = 0.41 for both).
Figure 1. Cortical lesions are more conspicuous on IR-SWIET.

(A) Axial slices of the image types used for cortical lesion identification: T2 weighted (w) fluid-attenuated inversion recovery (FLAIR), T1w magnetization-prepared 2 rapid acquisition gradient echoes (MP2RAGE), the ratio of MP2RAGE to FLAIR images (T1/T2), and Inversion Recovery Susceptibility Weighted Imaging with Enhanced T2 weighting (IR-SWIET). IR-SWIET was acquired four times per session and is shown as a single acquisition (×1), the average of two acquisitions (×2), the median of four acquisitions (×4), and a denoised single acquisition (×1DN). Red arrows indicate subpial lesions. (B–H) Magnified images of individual cortical lesions; black arrows indicate detected lesions; white, not detected; red, detected but misclassified; yellow, artifact. (B) Two subpial lesions identified on all IR-SWIET image types, with corresponding signal change visible on FLAIR and MP2RAGE in retrospect. (C-D) A subpial lesion identified on IR-SWIET×2, ×4, and ×1DN but not detected on FLAIR+MP2RAGE, T1/T2, or IR-SWIET×1. (E) A subpial lesion identified on FLAIR+MP2RAGE and all IR-SWIET image types but called possible subpial on T1/T2; yellow arrows indicate a division-related artifact on the T1/T2 image. (F) A leukocortical lesion identified on all image sets but classified as juxtacortical on T1/T2; yellow arrows indicate artifactual hyperintense signal at the pial surface. (G) A lesion identified as leukocortical on all image sets except IR-SWIET×1DN, where it was classified as subpial with white matter involvement, possibly related to smoothing of the lesion–cortex boundary by denoising. (H) A subpial lesion identified only on IR-SWIET×1DN but visible in retrospect on other image types.
Detection of subpial lesions with WM involvement also differed across image sets (Friedman χ2 = 25.12, p < 0.001). More subpial lesions with WM involvement were detected with IR-SWIET×1DN compared to MP2RAGE + FLAIR (p = 0.001, FDR p = 0.005) and IR-SWIET×1 (p = 0.006, FDR p = 0.02). IR-SWIET×2 and IR-SWIET×4 did not differ significantly from MP2RAGE + FLAIR alone after FDR correction.
Leukocortical lesion detection did not differ significantly across image sets (Friedman χ2 = 3.23, p = 0.68). Intracortical lesions were rare across all image sets (median 0 for all sequences); although there was a significant difference across image sets (Friedman χ2 = 12.41, p = 0.02), no pairwise comparison survived FDR correction.
Use of IR-SWIET increases the number of individuals with at least one detected subpial lesion
The proportion of individuals with at least one detected cortical lesion was high across all image sets (95–100%) and did not differ significantly across image sets (Cochran’s Q p = 0.63, Figure 2E). For subpial lesions, at least one subpial lesion was detected in 8/20 participants (40%) with MP2RAGE + FLAIR, vs 7/20 (35%) with T1/T2, 12/20 (60%) with IR-SWIET×1, 15/20 (75%) with IR-SWIET×2 and IR-SWIET×4, and 14/20 (70%) with IR-SWIET×1DN (Cochran’s Q, p < 0.001). More individuals had at least one detected subpial lesion with IR-SWIET×2 (p = 0.02, FDR p = 0.039) and IR-SWIET×4 (p = 0.02, FDR p = 0.039) compared with MP2RAGE + FLAIR; the difference in individuals with detected subpial lesions between IR-SWIET×1DN and MP2RAGE + FLAIR alone did not survive correction for multiple comparisons (p = 0.03, FDR p = 0.052).
Figure 2. More subpial lesions are detected using IR-SWIET.

(A–D) Boxplots of the number of cortical lesions identified on each image set in 20 participants. All image sets included fluid-attenuated inversion recovery (FLAIR) and magnetization-prepared 2 rapid acquisition gradient echoes (MP2RAGE). Each dot represents one individual; the center line indicates the median, the box the interquartile range, and the whiskers the highest and lowest values within 1.5 times the 1st and 3rd quartiles. The omnibus Friedman p value is shown above each panel. Significance brackets indicate pairwise comparisons against MP2RAGE + FLAIR (lower brackets) and against IR-SWIET×1 (upper brackets) (Wilcoxon signed-rank test with false discovery rate correction; * p < 0.05, ** p < 0.01; full results in Supplementary Table 2). Lesion counts were higher with the comparator image set in all significant comparisons except total cortical lesions on T1/T2, which were lower than on MP2RAGE + FLAIR. Intracortical lesions are not shown, as they were rare across all image sets (median 0). (E) The percentage of individuals with at least one detected cortical lesion (dark blue) was similar across image sets (95–100%; Cochran’s Q, p = 0.63), whereas the percentage with at least one subpial lesion (light blue) differed across image sets (Cochran’s Q, p < 0.001); pairwise McNemar comparisons are reported in the text and are not annotated here.
Interrater agreement for each image set
ICC estimates for total cortical, leukocortical, intracortical, and subpial lesions with white matter involvement showed no consistent pattern across image sets (Supplementary Table 3). ICC for subpial lesion counts was 0.66 (95% confidence interval [CI] 0.42 – 0.74) for IR-SWIET×4, 0.38 (CI 0.01 – 0.62) for IR-SWIET×2, 0.53 (CI 0.05 – 0.62) for IR-SWIET×1DN, 0.26 (CI −0.01 – 0.46) for IR-SWIET×1, 0.15 (CI 0.00 – 0.39) for T1/T2 and 0.29 (CI −0.09 – 0.79) for MP2RAGE + FLAIR (Supplementary Table 3).
The proportion of total cortical lesions identified independently by both raters was similar across image sets (53-65%). For subpial lesions, the proportion identified by both raters was 23% on MP2RAGE + FLAIR (10/44), 17% on T1/T2 (2/12), 37% on IR-SWIET×1 (21/57), 42% on IR-SWIET×2 (40/96), 50% on IR-SWIET×4 (51/103), and 56% on IR-SWIET×1DN (49/88).
Retrospective review of cortical lesion appearance on different images
To better understand differences in lesion detection, we performed a retrospective review of specific lesion subsets.
Subpial lesions identified on IR-SWIET but not on MP2RAGE + FLAIR
Of the 178 lesions identified as subpial on at least one IR-SWIET-containing image set but not identified as subpial on MP2RAGE + FLAIR, 135 (76%) were not identified at all, 25 (14%) were identified as leukocortical, 16 (9%) were identified as possible subpial, and 2 (1%) were identified as intracortical. Of the 135 lesions not identified on MP2RAGE + FLAIR, for 90 (67%), there was subtle signal change on at least one sequence on retrospective review (Figure 1B-D) and no visible signal change in 31 (23%). 14 lesions (10%) were clearly visible and were considered missed lesions.
Subpial lesions identified only on IR-SWIET×1DN images
Of the 88 subpial lesions identified on IR-SWIET×1DN, 20 (23%) were not identified as subpial on any other image set. Of these, 11 (55%) were identified as possible subpial on at least one other image set, 7 (35%) were not detected on any other image set, and 2 (10%) were identified as subpial with WM involvement. Of the 7 subpial lesions not detected on any other image set, in retrospect, 4/7 (57%) were visible on IR-SWIET×4, with the lesion appearing more conspicuous on the denoised image in 2 lesions and equally visible in 2 lesions (Figure 1H). For the remaining 3 lesions (43%), there was subtle but not convincing signal abnormality on IR-SWIET×4, MP2RAGE, or FLAIR.
17 lesions were identified as subpial lesions with WM involvement on IR-SWIET×1DN but were not identified as such on any other image set. Of these, 11 (65%) were identified as leukocortical on at least one other image set, 2 (12%) were called subpial on one other image set (IR-SWIET×2), 1 (6%) was called possible subpial on one other image set (IR-SWIET×4), and 3 (18%) were not identified on any other image set. In some cases, the hyperintense subpial surface was confluent with the lesion on the denoised image, possibly leading to misclassification of leukocortical lesions as subpial lesions with WM involvement (Figure 1G).
Differences in lesion detection and classification on MP2RAGE + FLAIR vs T1/T2
The 65 lesions identified on MP2RAGE + FLAIR but not T1/T2 were clearly visible in retrospect (Supplementary Table 4). We observed that on the T1/T2 images there were artifacts related to imperfect registration and distortion differences that sometimes obscured lesions or made it difficult to determine if a lesion was juxtacortical vs cortical (Figure 1E-F).
Associations between lesion counts and disability were similar across image sets
Associations between cortical lesion counts and clinical measures, adjusted for age, were broadly similar across image sets (Supplementary Figure 1). Higher total cortical lesion counts were associated with lower SDMT scores on all image sets except IR-SWIET×2 (ρ = −0.68 to −0.50; p < 0.05). Higher white matter lesion volume was also associated with lower SDMT scores (ρ = −0.61, p = 0.004). Higher total cortical lesion counts detected on MP2RAGE + FLAIR were associated with longer 9-HPT times (ρ = 0.49, p = 0.03), but this association was not significant on any other image set. No significant associations with EDSS or T25FW were observed.
Sensitivity of IR-SWIET×1DN is similar to IR-SWIET×2 when compared to 7T
To determine the sensitivity of cortical lesions detected on IR-SWIET×1DN, we performed a multi-contrast read using MP2RAGE, FLAIR, and IR-SWIET×1DN in a set of 10 scans from individuals with existing 3 and 7T-based cortical lesion segmentations. Cortical lesions identified on IR-SWIET×1DN were compared to previous 7T cortical lesion segmentations as well as to previous segmentations on MP2RAGE, FLAIR, and IR-SWIET×2.9 For total cortical lesions, IR-SWIET×1DN achieved a sensitivity of 34 ± 4% against the 7T reference, comparable to IR-SWIET×2 (sensitivity 40 ± 4%, p = 0.06). For subpial lesions, sensitivity with IR-SWIET×1DN was 25 ± 5%, similar to IR-SWIET×2 (sensitivity 30 ± 5%, p = 0.36, Table 3). Interrater agreement in this cohort was higher than in the UVM cohort (ICC 0.95, 95% CI 0.77 – 0.98 for total cortical lesions and 0.91, 0.49 – 0.97 for subpial lesions; Supplementary Table 5).
Table 3.
Comparison of cortical lesion detection using IR-SWIET×1DN with 7T reference standard
| 7T reference | IR-SWIET×1DN1 | IR-SWIET×21 | P values2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lesion type | Total | Median (IQR) [range] |
TP3 | FP4 | Median (IQR) [range] |
Sensitivity5 | TP | FP | Median (IQR) [range] |
Sensitivity | TP | Sensitivity |
| All cortical | 718 | 47 (73) [15–206] | 273 | 18 | 20 (29) [3–95] | 34 ± 4% | 336 | 22 | 16 (42) [4–111] | 40 ± 4% | 0.09 | 0.06 |
| Leukocortical | 182 | 16 (14) [0–42] | 97 | 16 | 8 (11) [0–23] | 50 ± 5% | 109 | 10 | 11 (5) [0–24] | 61 ± 4% | 0.19 | 0.11 |
| Intracortical | 26 | 3 (2) [0–6] | 2 | 0 | 0 (0) [0–1] | 17 ± 12% | 1 | 1 | 0 (0) [0–1] | 11 ± 11% | 1 | 1 |
| Subpial | 380 | 21 (51) [6–124] | 104 | 1 | 5 (9) [0–47] | 25 ± 5% | 147 | 10 | 5 (12) [0–63] | 30 ± 5% | 0.11 | 0.36 |
| Subpial with white matter involvement | 130 | 3 (15) [0–62] | 70 | 1 | 1 (12) [0–25] | 56 ± 9% | 79 | 1 | 1 (10) [0–35] | 54 ± 15% | 1 | 0.88 |
Lesions were identified on a multi-contrast read of IR-SWIET denoised single acquisition (IR-SWIET×1DN) or an average of two acquisitions (IR-SWIET×2), as well as MP2RAGE, and FLAIR.
Two-sided Wilcoxon signed-rank test between IR-SWIET×1DN and IR-SWIET×2.
TP: true positives, number of lesions identified on both 3T and 7T images.
FP: confirmed false positives, excluding lesions outside the 7T field of view and lesions considered true lesions missed on 7T retrospective review.
Proportion of 7T lesions detected per participant, mean ± standard error.
IR-SWIET: inversion recovery susceptibility weighted imaging with enhanced T2 weighting; MP2RAGE: magnetization prepared 2 rapid acquisition gradient echoes; FLAIR: fluid-attenuated inversion recovery; IQR: interquartile range.
Denoising IR-SWIET does not lead to an increase in false positive lesion detection
Of 327 cortical lesions identified on IR-SWIET×1DN, 54 (17%) were not originally identified on 7T images. On retrospective review of these lesions, 19 fell outside the 7T field of view and 4 could not be assessed owing to poor 7T image quality. Of the remaining 31, 13 were clearly visible on 7T images and were classified as missed (Figure 3B), and 18 (6% of all lesions identified) were considered false positives (16 leukocortical, one subpial, and one subpial with WM involvement, Figure 3D). Four of the leukocortical false positives appeared juxtacortical at 7T, and the other lesions did not have clear signal abnormality on 7T images. In comparison, 6% (22/358) lesions identified on IR-SWIET×2 were considered false positives, including 10 subpial lesions (Table 3).
Figure 3. Cortical lesion detection on IR-SWIET×1DN, with comparison to IR-SWIET×2 and 7T imaging.

Examples of cortical lesions on 7 tesla (T) and 3T images, including a single IR-SWIET acquisition (×1), an average of two acquisitions (×2), and a denoised single acquisition (×1DN). Black arrows indicate detected lesions; white, not detected. Cortical lesions were not identified on MP2RAGE and FLAIR alone or with IR-SWIET×1 here; yellow arrows therefore mark the lesion location on MP2RAGE, FLAIR, and IR-SWIET×1 without indicating whether the lesion was identified on those images. (A) Left: a subpial lesion identified on IR-SWIET×1DN, IR-SWIET×2, and at 7T. Right: a subpial lesion identified on IR-SWIET×1DN and at 7T, but not on IR-SWIET×2. (B) A subpial lesion identified on IR-SWIET×1DN that was not identified on 7T images but was visible on retrospective review. (C) A subpial lesion identified on IR-SWIET×2 and 7T images, but not on IR-SWIET×1DN, although it was visible on retrospective review. The superficial normal-appearing cortex appears more hyperintense on IR-SWIET×1DN than on IR-SWIET×2 and IR-SWIET×1, which may reduce lesion-to-cortex contrast and contribute to missed lesions on the denoised image. (D) A lesion identified on IR-SWIET×1DN but not on IR-SWIET×2 or on 7T images, considered a false positive on retrospective review, although subtle signal change was present on all IR-SWIET image types. T2* GRE: T2*-weighted gradient echo; MP2RAGE: magnetization-prepared 2 rapid acquisition gradient echoes; FLAIR: fluid-attenuated inversion recovery; IR-SWIET: Inversion Recovery Susceptibility Weighted Imaging with Enhanced T2 weighting.
Cortical lesion subtyping accuracy is similar for IR-SWIET×1DN and ×2 vs 7T
We determined the proportion of cortical lesions assigned the same subtype based on 3T and 7T images. 79% of leukocortical lesions and 89% of subpial lesions were accurately classified on IR-SWIET×1DN. For subpial lesions with WM involvement, 47% were accurately classified on IR-SWIET×1DN while 41% were identified as subpial. Accuracy was similar for IR-SWIET×2 (see Supplementary Results).
Discussion
Here we compared several 3T MRI approaches for cortical lesion detection. Our principal finding is that IR-SWIET significantly improves subpial cortical lesion detection compared to T1w MP2RAGE and T2w FLAIR imaging alone. In contrast, T1/T2 ratio imaging does not improve cortical lesion detection.
Consistent with our prior single-center study, IR-SWIET significantly improved subpial lesion detection.9 The increase in the proportion of individuals with at least one detectable subpial lesion from 40% with MP2RAGE and FLAIR to 70–75% with IR-SWIET is potentially clinically relevant for both diagnosis and prognosis.
Averaging two IR-SWIET acquisitions, which take ~5 minutes each to acquire, and denoising a single acquisition both improved subpial lesion detection in comparison to using one IR-SWIET acquisition, with little additional gain from a median of four. There were no major differences in sensitivity, false positive rate, or subtyping accuracy between denoised IR-SWIET and averaged IR-SWIET, suggesting that denoising offers an efficient and accurate alternative. We did observe that denoising sometimes results in a more uniform, hyperintense subpial cortical signal, occasionally making it difficult to differentiate leukocortical from subpial lesions with WM involvement. More sophisticated deep-learning based denoising strategies, incorporating prior knowledge of cortical lesion appearance on averaged vs single IR-SWIET images, may in the future result in even better image quality and cortical lesion conspicuity.
Notably, adding T1/T2 reduced cortical lesion detection, despite previous findings of increased lesion-to-tissue contrast and lesion conspicuity with this method. This may have been due to artifacts on T1/T2 images, including hyperintense signal at the pial surface and changes in grey–white matter contrast, which may have obscured lesions or contributed to misclassification. Both artifacts likely arise from imperfect registration and geometric distortion differences between the two image types. The cortex-CSF artifact might be compounded by the use of FLAIR images as opposed to T2 weighted images to generate T1/T2; because FLAIR suppresses CSF signal, division by values approaching zero may contribute to artifact at the cortex-CSF boundary.12,13 Different registration approaches, intensity normalization before division, or acquisition of both sequences at matched resolution could potentially mitigate some of these issues.13
Interrater agreement for cortical lesions was modest for all image sets evaluated which is a recognized challenge for cortical lesion identification.17 Higher ICC values have been reported at 3T, 0.89 for total cortical lesions and 0.81 for subpial lesions with IR-SWIET×2, MP2RAGE and FLAIR and 0.67–0.87 for cortical lesions on phase-sensitive inversion recovery (PSIR) and FLAIR.9,18,19 However, ICC improved in the 7T validation with IR-SWIET×1DN, MP2RAGE and FLAIR to 0.95 for total cortical lesions and 0.91 for subpial lesions. Modest agreement observed in the UVM cohort could reflect rater inexperience and low overall lesion numbers in the UVM cohort rather than a limitation of IR-SWIET itself. Interrater limitations could be addressed with automated cortical lesion detection methods currently under development.17
Several limitations warrant acknowledgement. A 7T reference standard was not available for the UVM cohort, precluding estimation of sensitivity and evaluation of false positives. Participants were selected for the presence of at least one cortical lesion visible on MP2RAGE, FLAIR and IR-SWIET; this could have biased results in favor of IR-SWIET. Another limitation is that currently IR-SWIET requires an average or post processing denoising for maximal subpial lesion detection, limiting its current potential for clinical use. However, scanner manufacturers are now implementing deep-learning based image reconstructions that dramatically reduce noise for other sequences, and in the future these methods could potentially be applied to IR-SWIET.
Overall, IR-SWIET significantly improves subpial cortical lesion detection at 3T. Averaging two acquisitions provides substantial benefit over a single acquisition, and denoising a single acquisition is a time-saving alternative to averaging multiple acquisitions. Larger, multicenter studies will be needed to determine the generalizability of these findings and the utility of IR-SWIET-detected cortical lesions for MS diagnosis and prognosis.
Supplementary Material
Supplementary material is available online.
Acknowledgements
We thank the participants for their time and contribution to this study, and the faculty and staff at the University of Vermont for their assistance with patient recruitment and study visits.
Funding
This study was funded by Bristol Myers Squibb and by an investigator-initiated research award from the Department of Defense (HT94252410914). This work was supported in part through the Minerva computational and data resources and staff expertise provided by Scientific Computing and Data at the Icahn School of Medicine at Mount Sinai and supported by the Clinical and Translational Science Awards (CTSA) grant UL1TR004419 from the National Center for Advancing Translational Sciences. This research was supported in part by the Intramural Research Program of the National Institutes of Health (D.S.R., ZIANS003119). The contributions of the NIH authors are considered Works of the United States Government. The findings and conclusions presented in this paper are those of the authors and do not necessarily reflect the views of the NIH or the US Department of Health and Human Services.
Footnotes
Competing interests
D.S.R. has received research support from Sanofi, unrelated to the present work. The other authors report no competing interests.
Data availability
The imaging and clinical data supporting the findings of this study are not publicly available because they contain information that could compromise participant privacy, but are available from the corresponding author on reasonable request and subject to institutional data-sharing agreements.
References
- 1.Harrison DM, Roy S, Oh J, et al. Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in multiple sclerosis. JAMA Neurol. 2015;72(9):1004–1012. doi: 10.1001/jamaneurol.2015.1241 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Mainero C, Benner T, Radding A, et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology. 2009;73(12):941–948. doi: 10.1212/WNL.0b013e3181b64bf7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Beck ES, Mullins WA, Dos Santos Silva J, et al. Contribution of new and chronic cortical lesions to disability accrual in multiple sclerosis. Brain Commun. 2024;6(3):fcae158. doi: 10.1093/braincomms/fcae158 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bø L, Vedeler CA, Nyland HI, Trapp BD, Mørk SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 2003;62(7):723–732. doi: 10.1093/jnen/62.7.723 [DOI] [PubMed] [Google Scholar]
- 5.Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173. doi: 10.1016/S1474-4422(17)30470-2 [DOI] [PubMed] [Google Scholar]
- 6.Montalban X, Lebrun-Frenay C, Oh J, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850–865. doi: 10.1016/S1474-4422(25)00270-4 [DOI] [PubMed] [Google Scholar]
- 7.Seewann A, Kooi EJ, Roosendaal SD, et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology. 2012;78(5):302–308. doi: 10.1212/WNL.0b013e31824528a0 [DOI] [PubMed] [Google Scholar]
- 8.Kober T, Granziera C, Ribes D, et al. MP2RAGE multiple sclerosis magnetic resonance imaging at 3 T. Invest Radiol. 2012;47(6):346–352. doi: 10.1097/RLI.0b013e31824600e9 [DOI] [PubMed] [Google Scholar]
- 9.Beck ES, Gai N, Filippini S, Maranzano J, Nair G, Reich DS. Inversion recovery susceptibility weighted imaging with enhanced T2 weighting at 3 T improves visualization of subpial cortical multiple sclerosis lesions. Invest Radiol. 2020;55(11):727–735. doi: 10.1097/RLI.0000000000000698 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Manjon JV, Carbonell-Caballero J, Lull JJ, Garcia-Marti G, Marti-Bonmati L, Robles M. MRI denoising using non-local means. Med Image Anal. 2008;12(4):514–523. doi: 10.1016/j.media.2008.02.004 [DOI] [PubMed] [Google Scholar]
- 11.Maggioni M, Katkovnik V, Egiazarian K, Foi A. Nonlocal transform-domain filter for volumetric data denoising and reconstruction. IEEE Trans Image Process. 2013;22(1):119–133. doi: 10.1109/TIP.2012.2210725 [DOI] [PubMed] [Google Scholar]
- 12.Manning AR, Beck ES, Schindler MK, et al. T1/T2 ratio from 3T MRI improves multiple sclerosis cortical lesion contrast. J Neuroimaging. 2023;33(3):434–445. doi: 10.1111/jon.13088 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Dwyer MG, Bergsland N, Bartnik A, et al. Quantifying cortical lesions in multiple sclerosis MRI datasets using multi-contrast post-processing and deep learning. Commun Med (Lond). 2026;6(1):365. doi: 10.1038/s43856-026-01683-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Manjon JV, Coupe P, Marti-Bonmati L, Collins DL, Robles M. Adaptive non-local means denoising of MR images with spatially varying noise levels. J Magn Reson Imaging. 2010;31(1):192–203. doi: 10.1002/jmri.22003 [DOI] [PubMed] [Google Scholar]
- 15.Dereskewicz E, La Rosa F, Dos Santos Silva J, et al. A novel convolutional neural network for automated multiple sclerosis brain lesion segmentation. J Neuroimaging. 2025;35(5):e70085. doi: 10.1111/jon.70085 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Liu J, Beck ES, Filippini S, et al. Navigator-guided motion and B0 correction of T2*-weighted magnetic resonance imaging improves multiple sclerosis cortical lesion detection. Invest Radiol. 2021;56(7):409–416. doi: 10.1097/RLI.0000000000000754 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.La Rosa F, Beck ES, Maranzano J, et al. Multiple sclerosis cortical lesion detection with deep learning at ultra-high-field MRI. NMR Biomed. 2022;35(8):e4730. doi: 10.1002/nbm.4730 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.de Caneda MAG, Rizzo MRL, Furlin G, et al. Interrater reliability for the detection of cortical lesions on phase-sensitive inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Radiol Bras. 2023;56(4):187–194. doi: 10.1590/0100-3984.2022.0116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Forslin Y, Bergendal A, Hashim F, et al. Detection of leukocortical lesions in multiple sclerosis and their association with physical and cognitive impairment: a comparison of conventional and synthetic phase-sensitive inversion recovery MRI. AJNR Am J Neuroradiol. 2018;39(11):1995–2000. doi: 10.3174/ajnr.A5815 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The imaging and clinical data supporting the findings of this study are not publicly available because they contain information that could compromise participant privacy, but are available from the corresponding author on reasonable request and subject to institutional data-sharing agreements.
